SS Innovations International, Inc.
SS Innovations International, Inc. develops, manufactures, and sells the SSi Mantra surgical robotic system and related SSi Mudra instruments and accessories. The company is based in the United States but its manufacturing and commercial footprint is centered in India, with sales and support activities extending into selected international markets.
Fiscal year 2025 · change from previous year
Development 2020–2025
Business
Share of revenueThe SSi Mantra robotic platform sold to hospitals and surgical centers.
Reusable and consumable instruments, accessories, and stocking orders for installed systems.
Warranty coverage, readiness support, maintenance plans, and technical support services.
Recurring income from systems placed under usage-based or deferred commercial models.
Products
Reported · share of revenue- System Sales90.3 %
- Instruments Sale7.5 %
- Warranty Sale2.1 %
- Lease Income0.2 %
Source: 10-K FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.
Customers
Customers are hospitals, surgical centers, and physicians that acquire robotic surgery systems for use in urology, general surgery, gynecology, colorectal, gastroenterology, head and neck, thoracic, and cardiac procedures. The company also serves customers that prefer usage-based or deferred payment structures, which lowers upfront adoption barriers for capital-constrained healthcare providers.
Buy SSi Mantra systems for operating room use across multiple specialties and to build robotic surgery programs.
Use the platform and buy into training, proctoring, and support services to adopt robotic procedures.
Reorder instruments, accessories, warranty coverage, and maintenance services after system installation.
Adopt pay-per-procedure or deferred models to access the system with lower upfront capital needs.
Strategy
The company’s strategy is to expand access to surgical robotics by offering a lower-cost, next-generation system with flexible commercial models. It is also building recurring revenue through instruments, accessories, service plans, and usage-based arrangements while broadening regulatory approvals and market reach.
A larger installed base supports system sales, instrument pull-through, and service revenue.
Instruments, accessories, warranty, and service plans create repeat revenue after system placement.
New instruments and specialty applications increase the number of procedures the platform can support.
Approvals are needed to sell in regulated markets and to scale beyond current geographies.
Geography
Q1/2026Substantially all reported sales have been in India, with additional individual sales in the United Arab Emirates, Ecuador, Iraq, Nepal, Colombia, Indonesia, and the Philippines. Manufacturing operations are based in India, which also supports the company’s service network and distributor relationships.
Share of the revenue the company reports by geography.
Risks
The business depends on continued adoption of a relatively new robotic platform, successful regulatory approvals, and the ability to finance growth. It also faces execution risk around manufacturing, service quality, and customer uptake of alternative payment models, along with the usual risks of a capital-intensive medical device company.
Sales in regulated markets depend on obtaining and maintaining approvals for the robotic system and related devices.
Exposure: International expansion
The company has relied on debt and equity offerings and may need additional capital to fund operations and expansion.
Exposure: Corporate funding
Substantially all sales have been in India, so demand or policy changes there would affect results disproportionately.
Exposure: India
Robotic surgery adoption depends on surgeon acceptance, hospital budgets, and willingness to switch from established systems.
Exposure: System sales
The model requires reliable production, installation, maintenance, and technical support to protect customer uptime.
Exposure: India operations and distributor network
Accounting
Judgemental itemsDifferent sales structures recognize revenue at different times, affecting comparability across periods.
Impact: System sales, lease income, and recurring service revenue
Bundled contracts require allocation across systems, instruments, accessories, and services.
Impact: Reported mix and timing of revenue
Fair value estimates and vesting schedules can create large non-cash expenses and volatility.
Impact: Operating expenses and net loss
Financial statements assume continued access to capital even though funding is not committed.
Impact: Liquidity disclosures and investor risk assessment
Similar listed companies
Publicly listed companies with a comparable business focus.
Shoulder Innovations, Inc
SI · Surgical & Medical Instruments & Apparatus
Intuitive Surgical, Inc
ISRG · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical designs and sells robotic-assisted surgical systems and related instruments, accessories, software, and services used to perform minimally invasive procedures.
Vicarious Surgical Inc.
RBOT · Orthopedic, Prosthetic & Surgical Appliances & Supplies
SS&C Technologies Holdings Inc
SSNC · Services-Prepackaged Software
SS&C Technologies Holdings is a U.S.-based provider of software and software-enabled services for financial services and healthcare organizations.
Stryker Corporation
SYK · Surgical & Medical Instruments & Apparatus
Stereotaxis, Inc.
STXS · Electromedical & Electrotherapeutic Apparatus
Stereotaxis designs and sells robotic magnetic navigation systems used in minimally invasive cardiac and endovascular procedures.
Last updated: 24/09/2026